Dr. Jaffe did her medical studies at Cornell University Medical College and the University of Pennsylvania, receiving the M.D. from the latter. Her post-graduate medical education was completed at Georgetown University Hospital and the National Cancer Institute of the National Institutes of Health. She has been Chief of the Hematopathology Section at the NCI since 1980. Her clinical and investigational studies have been intertwined to enhance our understanding of the malignant lymphomas. One of her earliest papers on follicular lymphoma (1974), a Citation Classic, presented evidence for the origin of this tumor from follicular B cells. More recently she described in situ follicular lymphomas, which provide insight into the earliest events of follicular lymphomagenesis, and identified histiocytic/dendritic cell tumors arising in follicular lymphoma, providing the first evidence for lineage plasticity in mature human lymphoid cells. Her work stresses the clinical implications of diagnoses, emphasizing the role as pathologists as clinical consultants. She is an author of more than 490 peer reviewed articles, 35 invited editorials, and more than 130 chapters and invited reviews. Dr. Jaffe was an Editor for both the 2001 and 2008 editions of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. She is currently one of four series editors developing the 4th Edition Series of monographs for the classification of human tumors, under the auspices of the International Agency for Research on Cancer and the World Health Organization. Science Watch named her among the 10 most highly cited researchers in clinical oncology from 1981 and 1998. Dr. Jaffe has been president of both the Society for Hematopathology as well as the United States and Canadian Academy of Pathology. She has held several leadership positions in the American Society of Hematology. Among her awards are the Fred W. Stewart Award from Memorial-Sloan Kettering Cancer Center, the Lennert prize from the European Association for Haematopathology, and the Maude Abbott Lecturer for the United States and Canadian Academy of Pathology. Dr. Jaffe was recognized for her outstanding mentoring abilities with awards from the National Cancer Institute and the American Society of Investigative Pathology. Her fellows have gone on to academic success, with prestigious appointments in the United States, Europe and Asia. Dr. Jaffe was awarded an honorary degree (Honoris Causa) from the University of Barcelona, and received the Distinguished Graduate Award from the University of Pennsylvania School of Medicine in 2011. She has served on more than journal editorial boards, including The American Journal of Pathology, The American Journal of Surgical Pathology, Blood, Cancer Research, and Modern Pathology. In 1993, she was elected a fellow of the American Association for the Advancement of Science, and subsequently was elected Chair of the Medical Sciences Section of AAAS. She was elected to the Institute of Medicine of the National Academies in 2008. In 2013 Dr. Jaffe was award the Stratton Medal from the American Society of Hematology. In 2019 Dr. Jaffe was named an NIH Distinguished Investigator. Her further recognition includes the Maude Abbot Lecture and the Distinguished Pathologist Award (USCAP), and the Rous-Whipple and Gold Headed Cane Awards (ASIP).
show More
Preview
Evolution over the last 10 years of activity
Aggregated career metrics
1087
Total documents
5.02
Normalized Impact
417
Highly Cited Papers (10%)
29.99
International Collab. (%)
Most cited publications
Main coauthors
Following you can review Elaine's accomplishments in each of the dimensions.
The perfect present for a young Researcher!
Let's do it!
Dimensions One by One
Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic
attributes.
Each dimension includes a set of indicators and has a especific weight on the One Index.
More information here...
Activity
997
/1000
Reflects an author's research output.
Impact
988
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Excellence
986
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Leadership
687
/1000
Reflects an author's efforts and commitment in leading research initiatives.
Cooperation
911
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
Openness
972
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.
Community Support
414
/1000
Reflects an author's contributions to the academic community beyond their own research.
Community Recognition
0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
Transference
166
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
Fundraising
0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
All indicators
Performance
Activity
Reflects an author's research output.
| Documents | 1087 | Count of all document types. |
|---|---|---|
| Docs/Year | 20.13 | Average of documents published by author per year. |
| Citable docs | 951 | Count of journal articles, proceeding papers and reviews. |
| Journal Articles | 874 | Documents published as articles in scientific journals usually peer-reviewed. |
| Conferences | 1 | Original article reporting data presented at a conference or symposium. |
| Reviews | 76 | Review papers authored by the researcher. |
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
| Theses | 0 | Document submitted in support of candidature for an academic degree or professional qualification presenting the author's research and findings |
| Books | 4 | A whole monograph or the entire book. |
| Book Chapters | 0 | Complete chapter in a book or book series volume where the item is identified as a chapter by a heading or section indicator. |
| Datasets | 14 | Number of dataset where the author have contributed to the creation. |
| Editorials | 7 | Papers where the author contributed editorial content. |
| Reports | 0 | Research reports or white papers authored. |
| Grants | 0 | Research projects funded through external grants awarded to the author. |
| Pre-Prints | 14 | Number of publications freely available in pre-print format. |
| Clinical Trials | N/A | Number of clinical trials where the author has participated. |
| Other types | 0 | Other type of documents. |
Impact
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citations | 120486 | Total number of citations to all the publications attributed to the author (all types). |
|---|---|---|
| Self Citations | 3420 | Citations where the author references their own previous work. |
| Self Citation Rate | 2.839 | Percentage of self-citations in the author's total citation count. |
| Non Self Citation Rate | 97.161 | Percentage of citations received from sources that are not self-citations. |
| Hot Citations | 2316 | Total number of citations recieved in the last 6 months. |
| Citations/Document | 110.84 | Average of citations recieved per document. |
| % Not Cited | 0.0 | Percentage of documents with no citations recieved. |
| Relative Citation Index | 5.015 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and discipline. An author's RCI corresponds to the average of the values of his/her publications. |
| Journal Relative Citation Index | 3.92 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and journal. An author's RCI corresponds to the average of the values of his/her publications. |
| H Index | 162 | Maximum value of h such that the given author has published at least h papers that have each been cited at least h times. |
| G Index | 321 | Maximum value of g such that the given author has published at least g papers that have each been cited at least g^2 times. |
| i10 Index | 720 | Number of documents with at least 10 citations recieved. |
Excellence
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citation Score | 0.714 | Ratio between 0 and 1 being 0 corresponding to the citation percentile being 0 the 0th and 1 the 100th. |
|---|---|---|
| Citation Normalized Percentile | 0.699 | Citation percentile normalized to 1 (0 worst, 1 best) of the position in citations rankin within the field. Provided by OpenAlex. |
| Higly Cited Papers (top 10%) | 417 | Count of publications falling on or above the 90th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Higly Cited Papers | 3.836 | Quotient between the real number of Highly Cited Papers (HCP) and expected number of HCP's that is the 10% of total documents. |
| Outstanding Papers (top 1%) | 97 | Count of publications falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Outstanding Papers | 8.924 | Quotient between the real number of Outstanding Papers (OP) and expected number of OP's that is the 1% of total documents. |
| Outstanding Papers (top 0.1%) | 16 | Count of publications falling on or above the 99.9th citation percentile in the cohort of publications of the same type, year and discipline. |
| Hot Papers | 72 | Using only the citations recieved in the last 6 months: documents falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
Interaction within community
Leadership
Reflects an author's efforts and commitment in leading research initiatives.
| Docs Leadership | 379 | Number of documents lead by the author. |
|---|---|---|
| % Leadership | 34.87 | Percentage of documents lead by the author. |
| Docs International Leadership | 66 | Number of documents in international collaboration lead by the author. |
| % International Leadership | 6.07 | Percentage of documents in international collaboration lead by the author. |
| Principal Investigator | 0 | Number of times where the author served as the lead researcher in a project. |
| Associations Founded | 0 | Number of associations founded by the author. |
| Societies Founded | 0 | Number of scientific or professional societies established by the author. |
| Foundations Founded | 0 | Number of research-related foundations established by the author. |
| Councils | 0 | Number of councils founded by author. |
Cooperation
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
| Authors/Paper | 13.06 | Average number of authors per document. |
|---|---|---|
| % Highly Authored Papers | 11.04 | Percentage of documents with 25 or more authors. |
| Countries/Paper | 1.73 | Average number of different countries in the author's affiliation line per document. |
| Docs International Collaboration | 326 | Number of documents reporting two or more different countries in the author's affiliation line. |
| % International Collaboration | 29.99 | Percentage of documents reporting two or more diffetent countries in the author's affiliation line. |
Community Support
Reflects an author's contributions to the academic community beyond their own research.
| Peer Review Counts | 3 | Number of times the author peer-reviewed publications. |
|---|---|---|
| Society Membership | 0 | Number of societies of wich the author is a member. |
| Society Memberships | 0 | Memberships held by the author in scientific or professional societies. |
| Editorial Board Memberships | 0 | Number of journals where the author has been member of editorial board. |
| Panelists | 0 | Number of times the author have been a panelist in the European Research Council (ERC) calls. |
Community Recognition
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
| Distinctions | 0 | Number of times the author have recieved a distinction for its career. |
|---|---|---|
| Invitations | 0 | Number of times the author has been invited to talks, professorships, expositions or demonstrations. |
| Talks | 0 | Number of times the author has been invited to talks. |
| Professorships | 0 | Number of times the author has been invited to professorhips. |
| Commissioned Reports | 0 | Commissioned reports done by the author. |
Interaction with society
Openness
Reflects an author's commitment to making their research freely accessible and open to the public.
| Open Access Documents | 536 | Number of documents in Open Access mode. |
|---|---|---|
| % Open Access Documents | 49.31 | Percentage of documents in Open Access mode. |
| Open Access Gold | 57 | Number of documents published in an OA journal that is indexed by the DOAJ. |
| Open Access Green | 154 | Toll-access on the publisher landing page, but there is a free copy in an OA repository. |
| Open Access Hybrid | 27 | Free under an open license in a toll-access journal. |
| Open Access Bronze | 298 | Free to read on the publisher landing page, but without any identifiable license. |
| Open Access Closed | 551 | Non Open Access documents. |
Transference
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
|---|---|---|
| Advisory Boards | 0 | Number of advisory boards of which the author is member. |
| Companies | 0 | Number of companies created or founded by the author. |
Fundraising
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
| Funding Counts | 0 | Number of activities reported as funding recieved. |
|---|---|---|
| ERC Grantees | 0 | Researchers awarded grants from the European Research Council. |